Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
format_facet:"Aufsätze"
topic_facet:"610"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=topic_facet%3A%22610%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=6
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=topic_facet%3A%22610%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=6
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=topic_facet%3A%22610%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=6
PubPharm (8.942)
51
A RANDOMIZED, DOUBLED-BLIND, DOUBLE-DUMMY, PLACEBO CONTROLLED MULTI-CENTRE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FLUTICASONE FUROATE INHALATION POWDER AND FLUTICASONE PROPIONATE INHAATION POWDER IN THE TREATMENT OF ASTHMA IN ADULTS AND ADOLESCENTS NOT CURRENTLY TREATED WITH INHALED CORTICOSTEROIDS : A RANDOMIZED, DOUBLED-BLIND, DOUBLE-DUMMY, PLACEBO CONTROLLED MULTI-CENTRE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FLUTICASONE FUROATE INHALATION POWDER AND FLUTICASONE PROPIONATE INHAATION POWDER IN THE TREATMENT OF ASTHMA IN ADULTS AND ADOLESCENTS NOT CURRENTLY TREATED WITH INHALED CORTICOSTEROIDS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
52
A DOSE-RANGING STUDY OF VILANTEROL (VI) INHALATION POWDER IN CHILDREN AGED 5-11 YEARS WITH ASTHMA ON A BACKGROUND OF INHALED CORTICOSTEROID THERAPY : A DOSE-RANGING STUDY OF VILANTEROL (VI) INHALATION POWDER IN CHILDREN AGED 5-11 YEARS WITH ASTHMA ON A BACKGROUND OF INHALED CORTICOSTEROID THERAPY
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
53
RANDOMIZED STUDY OF STAGE THALIDOMIDE (NSC 66847) MORE DEXAMETHASONE, VERSUS DEXAMETHASONE IN PATIENTS WITH RECENT DIAGNOSIS OF MULTIPLE MYELOMA. : RANDOMIZED STUDY OF STAGE THALIDOMIDE (NSC 66847) MORE DEXAMETHASONE, VERSUS DEXAMETHASONE IN PATIENTS WITH RECENT DIAGNOSIS OF MULTIPLE MYELOMA.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
54
A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO-CONTROLLED, PHASE III EFFICACY AND SAFETY STUDY OF BENRALIZUMAB (MEDI-563) ADDED TO HIGH-DOSE INHALED CORTICOSTEROID PLUS LONG-ACTING β2 AGONIST IN PATIENTS WITH UNCONTROLLED ASTHMA (SIROCCO) : A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO-CONTROLLED, PHASE III EFFICACY AND SAFETY STUDY OF BENRALIZUMAB (MEDI-563) ADDED TO HIGH-DOSE INHALED CORTICOSTEROID PLUS LONG-ACTING β2 AGONIST IN PATIENTS WITH UNCONTROLLED ASTHMA (SIROCCO)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
55
PLACEBO CONTROLLED EFFICACY AND SAFETY STUDY OF MOMETHASONE FUROATE ADMINISTERED BY DRY POWDER INHALER IN THE TREATMENT OF ASTHMA IN CHILDREN PREVIOUSLY MAINTAINED WITH INHALED CORTICOSTEROIDS : PLACEBO CONTROLLED EFFICACY AND SAFETY STUDY OF MOMETHASONE FUROATE ADMINISTERED BY DRY POWDER INHALER IN THE TREATMENT OF ASTHMA IN CHILDREN PREVIOUSLY MAINTAINED WITH INHALED CORTICOSTEROIDS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
56
CORTICOSTEROID RANDOMISATION AFTER SIGNIFICANT HEAD INJURY : CORTICOSTEROID RANDOMISATION AFTER SIGNIFICANT HEAD INJURY
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
57
Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting : PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE SAFETY AND EFFICACY OF THE INTRAVENOUS AND ORAL FORMULATIONS OF THE ANTAGONIST RECEPTOR OF NEUROKININ-1, CASOPITANT (GW679769) IN COMBINATION WITH ONDANSETRON AND DEXAMETHASONE FOR PREVENTION OF NAUSEA AND VOMITING INDUCED BY MODERATELY EMETOGENIC CHEMOTHERAPY
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
58
A 26-WEEK, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, ACTIVE CONTROLLED, MULTICENTER, MULTINATIONAL SAFETY STUDY EVALUATING THE RISK OF SERIOUS ASTHMA-RELATED EVENTS DURING TREATMENT WITH SYMBICORT® , A FIXED COMBINATION OF INHALED CORTICOSTEROID (ICS) (BUDESONIDE) AND A LONG ACTING ß2 - AGONIST (LABA)(FORMOTEROL) AS COMPARED TO TREATMENT WITH ICS (BUDESONIDE) ALONE IN ADULT AND ADOLESCENT (≥12 YEARS OF AGE) PATIENTS WITH ASTHMA. : A 26-WEEK, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, ACTIVE CONTROLLED, MULTICENTER, MULTINATIONAL SAFETY STUDY EVALUATING THE RISK OF SERIOUS ASTHMA-RELATED EVENTS DURING TREATMENT WITH SYMBICORT® , A FIXED COMBINATION OF INHALED CORTICOSTEROID (ICS) (BUDESONIDE) AND A LONG ACTING ß2 - AGONIST (LABA)(FORMOTEROL) AS COMPARED TO TREATMENT WITH ICS (BUDESONIDE) ALONE IN ADULT AND ADOLESCENT (≥ 12 YEARS OF AGE) PATIENTS WITH ASTHMA.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
59
A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BMS-188667 (ABATACEPT) OR PLACEBO ON A BACKGROUND OF MYCOPHENOLATE MOFETIL (MMF) AND CORTICOSTEROIDS IN THE TREATMENT OF ADULTS WITH ACTIVE CLASS III OR IV LUPUS NEPHRITIS : A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BMS-188667 (ABATACEPT) OR PLACEBO ON A BACKGROUND OF MYCOPHENOLATE MOFETIL (MMF) AND CORTICOSTEROIDS IN THE TREATMENT OF ADULTS WITH ACTIVE CLASS III OR IV LUPUS NEPHRITIS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
60
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
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
[1]
« Vorheriger
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[895]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Filter aufheben
Medienart: Aufsätze
Filter aufheben
Thema: 610
Medienart
Aufsätze
8.942
E-Artikel
8.942
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
610
8.620
Study Type: Interventional
3.992
Recruitment Status: Not yet recruiting
2.142
Phase: Phase 3
1.648
Recruitment Status: Completed
1.434
Recruitment Status: Authorised-recruitment may ...
1.262
Recruitment Status: Recruiting
1.210
Phase: Phase 2
618
Phase: Phase 4
284
Phase: Phase 2/Phase 3
268
Recruitment Status: Complete: follow-up complete
266
Study Type: Observational
240
Phase: Phase 1
174
Medical Condition: Health Condition 1: O- Medic...
134
Medical Condition: Multiple Myeloma MedDRA vers...
84
Phase: Other
82
Medical Condition: Multiple Myeloma
58
Medical Condition: Asthma MedDRA version: 18.1L...
56
Medical Condition: Asthma MedDRA version: 20.0L...
56
Medical Condition: Multiple myeloma MedDRA vers...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
5.178
2020-
3.764
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
8.770
Englisch
122
Unbestimmt
26
Spanisch
12
Französisch
4
Dänisch
4
Deutsch
2
Tschechisch
2
Niederländisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...